Zealthy is a coordination-heavy program with a layered bill. Competitive 3-month medication pricing, coaching, and help navigating insurance are real strengths. But the separate ~$135/mo membership raises the true cost, it does not clearly name its compounding pharmacy, and public reviews are mixed.
Zealthy at a glance
- Category:
- Telehealth weight-loss (GLP-1)
- Medication:
- Compounded semaglutide & tirzepatide (not FDA-approved)
- Semaglutide:
- ~$151/mo on a 3-month supply + ~$135/mo membership
- Tirzepatide:
- ~$216/mo on a 3-month supply + ~$135/mo membership
- Bundled option:
- Sema $217 first month then $297/mo; tirz $349 first month then $449/mo
- Membership fee:
- ~$135/mo (medication separate)
- Pharmacy:
- Not clearly named (verify)
- Reviews:
- Rating pending verification
- Clinical model:
- Providers + health coaches + insurance coordination
- Regulatory note:
- Some third-party reviews report billing complaints (verify); no action confirmed to a primary source
Pros and cons
What we like
- Competitive medication pricing on a 3-month supply
- Insurance coordination support
- Health coaching alongside prescribing providers
- Semaglutide and tirzepatide both offered
Trade-offs to know
- Separate ~$135/mo membership raises the true cost
- Does not clearly name its compounding pharmacy
- Mixed public reviews
- Bundled pricing jumps after the first month
- Medication is compounded — not FDA-approved
Scorecard
Scored on the same five-criterion rubric we apply to every provider. Weights in parentheses.
Pricing: watch the membership
On a 3-month supply, Zealthy advertises compounded semaglutide around $151/mo and compounded tirzepatide around $216/mo — competitive medication pricing. But it bills a separate weight-loss membership of about $135/mo, with the medication charged on top, so the true monthly cost is higher than the medication sticker alone. A bundled option runs about $217 the first month then $297/mo for semaglutide, and about $349 the first month then $449/mo for tirzepatide, so watch the jump after month one. If you value a single predictable number, a flat all-in program will be easier to budget.
Pharmacy & sourcing
Zealthy does not clearly name its current compounding pharmacy in its published materials (verify). Because compounded drugs are not FDA-approved, an undisclosed pharmacy removes a key way for patients to verify sourcing and request a certificate of analysis. This weighs on Zealthy's score regardless of its coordination strengths.
Reviews & reputation
We have not verified Zealthy's third-party rating to a primary source, so we show its rating as pending verification rather than publish an unconfirmed number. Public listings such as ConsumerAffairs show a mix of positive and negative experiences, with reported negatives tending to cluster around billing and communication rather than clinical care. Check current listings, as review volume and averages move over time.
Regulatory context
As of June 2026, we have not confirmed any regulatory action or lawsuit against Zealthy to a primary source. Some third-party reviews report billing complaints; treat those as unverified and check current listings and public dockets yourself. We present this factually, not as an accusation, and do not assert details we cannot source.
Who Zealthy is best for
Choose Zealthy if you specifically want help coordinating insurance and value coaching, and you're comfortable with a separate ~$135/mo membership. Consider our #1 pick instead if you want one flat, predictable price and a provider that names its pharmacy — see our MaxLife review.
Zealthy FAQ
How much does Zealthy really cost?
On a 3-month supply, Zealthy advertises compounded semaglutide around $151/mo and compounded tirzepatide around $216/mo, plus a separate weight-loss membership of about $135/mo, so the true monthly cost is higher than the medication price alone. A bundled option runs about $217 the first month then $297/mo for semaglutide, and about $349 the first month then $449/mo for tirzepatide. Verify current pricing on getzealthy.com.
Does Zealthy name its compounding pharmacy?
Not clearly. Zealthy does not clearly name its current compounding pharmacy in its published materials (verify). Because compounded drugs are not FDA-approved, an undisclosed pharmacy removes a key way to verify sourcing.
Is Zealthy FDA-approved?
Zealthy's compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Compounded semaglutide is not Ozempic® or Wegovy®; compounded tirzepatide is not Mounjaro® or Zepbound®.